- Home
- Publications
- Publication Search
- Publication Details
Title
Dopamine receptor agonists for Parkinson's disease
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 23, Issue 3, Pages 387-410
Publisher
Informa Healthcare
Online
2013-12-09
DOI
10.1517/13543784.2014.869209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the Efficacy of Pramipexole for Treating Levodopa-induced Dyskinesia in Patients with Parkinson's Disease
- (2014) Hiroya Utsumi et al. INTERNAL MEDICINE
- Inhaled dry powder apomorphine (VR040) for ‘off ’ periods in Parkinson's disease: an in-clinic double-blind dose ranging study
- (2013) K. A. Grosset et al. ACTA NEUROLOGICA SCANDINAVICA
- Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil
- (2013) Stéphane Thobois et al. BRAIN
- A Single-Center, Cross-Sectional Prevalence Study of Impulse Control Disorders in Parkinson Disease
- (2013) Michele Poletti et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Novel surface modified polymer–lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation
- (2013) Chandrakantsing V. Pardeshi et al. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
- Pramipexole Reduces Phosphorylation of α-Synuclein at Serine-129
- (2013) Kai-Yin Chau et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Neural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease
- (2013) Fabio Blandini Journal of Neuroimmune Pharmacology
- Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial
- (2013) Anthony HV Schapira et al. LANCET NEUROLOGY
- Effect of long-term treatment with pramipexole or levodopa on presynaptic markers assessed by longitudinal [123I]FP-CIT SPECT and histochemistry
- (2013) Candan Depboylu et al. NEUROIMAGE
- Rotigotine and specific non-motor symptoms of Parkinson's disease: Post hoc analysis of RECOVER
- (2013) K. Ray Chaudhuri et al. PARKINSONISM & RELATED DISORDERS
- Ropinirole protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism
- (2013) Gunhyuk Park et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls
- (2012) J.L. Riddle et al. BEHAVIOURAL BRAIN RESEARCH
- Efficacy and Safety of Extended- Versus Immediate-Release Pramipexole in Japanese Patients With Advanced and L-dopa–Undertreated Parkinson Disease
- (2012) Yoshikuni Mizuno et al. CLINICAL NEUROPHARMACOLOGY
- Moving from continuous dopaminergic stimulation to continuous drug delivery in the treatment of Parkinson’s disease
- (2012) O. Gershanik et al. EUROPEAN JOURNAL OF NEUROLOGY
- Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson’s disease
- (2012) A. H. V. Schapira et al. EUROPEAN JOURNAL OF NEUROLOGY
- New pharmacological avenues for the treatment ofl-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors
- (2012) Fabio Blandini et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Rotigotine transdermal patch for the treatment of Parkinson’s Disease
- (2012) Santiago Perez-Lloret et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- New prospective in treatment of Parkinson's disease: Studies on permeation of ropinirole through buccal mucosa
- (2012) V. De Caro et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The effect of piribedil on l-DOPA-induced dyskinesias in a rat model of Parkinson’s disease: differential role of α2 adrenergic mechanisms
- (2012) Manfred Gerlach et al. JOURNAL OF NEURAL TRANSMISSION
- Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
- (2012) Peter A. LeWitt et al. JOURNAL OF NEURAL TRANSMISSION
- Pramipexole Upregulates Dopamine Receptor D2 and D3 Expression in Rat Striatum
- (2012) Naohito Tokunaga et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Impulse Control and Related Disorders in Parkinsons Disease
- (2012) Daniel Weintraub et al. Neurodegenerative Diseases
- Pramipexole-Induced Increased Probabilistic Discounting: Comparison Between a Rodent Model of Parkinson's Disease and Controls
- (2012) Sandra L Rokosik et al. NEUROPSYCHOPHARMACOLOGY
- Pardoprunox as adjunct therapy to levodopa in patients with Parkinson’s disease experiencing motor fluctuations: Results of a double-blind, randomized, placebo-controlled, trial
- (2012) O. Rascol et al. PARKINSONISM & RELATED DISORDERS
- fMRI changes in cortical activation during task performance with the unaffected hand partially reverse after ropinirole treatment in de novo Parkinson's disease
- (2012) Carlo Tessa et al. PARKINSONISM & RELATED DISORDERS
- Preparation of Rotigotine-Loaded Microspheres and Their Combination Use with L-DOPA to Modify Dyskinesias in 6-OHDA-Lesioned Rats
- (2012) Aiping Wang et al. PHARMACEUTICAL RESEARCH
- Impulse control disorders in Parkinson’s disease: seeking a roadmap toward a better understanding
- (2011) Roberto Cilia et al. Brain Structure & Function
- Impulse control disorders in Parkinsonʼs disease
- (2011) Valerie Voon et al. CURRENT OPINION IN NEUROLOGY
- Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson’s disease
- (2011) K. Ray Chaudhuri et al. EUROPEAN JOURNAL OF NEUROLOGY
- Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6-OHDA-lesioned rats
- (2011) Maria Papathanou et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Pramipexole extended release in Parkinson’s disease
- (2011) Eva-Maria Hametner et al. Expert Review of Neurotherapeutics
- Pramipexole Reduces the Prevalence of Fatigue in Patients with Parkinson's Disease
- (2011) Akihiko Morita et al. INTERNAL MEDICINE
- Long-term, Open-label Study of Once-daily Ropinirole Prolonged Release in Early Parkinson's Disease
- (2011) Robert A. Hauser et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double-blind trials
- (2011) Cristina Sampaio et al. MOVEMENT DISORDERS
- PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease
- (2011) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- Extended-release pramipexole in early Parkinson disease: A 33-week randomized controlled trial
- (2011) W. Poewe et al. NEUROLOGY
- Extended-release pramipexole in advanced Parkinson disease: A randomized controlled trial
- (2011) A. H. V. Schapira et al. NEUROLOGY
- Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease
- (2011) Marie Therese Armentero et al. PHARMACOLOGY & THERAPEUTICS
- In vivo effects of pardoprunox (SLV308), a partial D2/D3 receptor and 5-HT1A receptor agonist, on rat dopamine and serotonin neuronal activity
- (2011) Cécile Bétry et al. SYNAPSE
- Impulse Control Disorders in Parkinson Disease
- (2010) Daniel Weintraub et al. ARCHIVES OF NEUROLOGY
- Pre-treatment with dopamine agonists influence l-dopa mediated rotations without affecting abnormal involuntary movements in the 6-OHDA lesioned rat
- (2010) Emma L. Lane et al. BEHAVIOURAL BRAIN RESEARCH
- An in vivo pharmacological evaluation of pardoprunox (SLV308) — A novel combined dopamine D2/D3 receptor partial agonist and 5-HT1A receptor agonist with efficacy in experimental models of Parkinson's disease
- (2010) C.A. Jones et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Effects of pramipexole on impulsive choice in male wistar rats.
- (2010) Gregory J. Madden et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- The partial dopamine agonist pardoprunox (SLV308) administered in combination with l-dopa improves efficacy and decreases dyskinesia in MPTP treated common marmosets
- (2010) K. Tayarani-Binazir et al. EXPERIMENTAL NEUROLOGY
- A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation
- (2010) Angelo Antonini et al. JOURNAL OF NEUROLOGY
- Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease
- (2010) Juliana Bronzova et al. MOVEMENT DISORDERS
- The use of Fogs' test to assess associated movements in Parkinsonism, dystonia, and controls
- (2010) Keiran K. Tuck et al. MOVEMENT DISORDERS
- Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo-controlled, randomized, double-blind, cross-over study
- (2010) Olivier Rascol et al. MOVEMENT DISORDERS
- Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP-treated common marmosets
- (2010) Louisa Clare Johnston et al. MOVEMENT DISORDERS
- Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER)
- (2010) Claudia Trenkwalder et al. MOVEMENT DISORDERS
- Twice-daily, low-dose pramipexole in early Parkinson's disease: A randomized, placebo-controlled trial
- (2010) Karl Kieburtz et al. MOVEMENT DISORDERS
- Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets
- (2010) Kayhan A. Tayarani-Binazir et al. MOVEMENT DISORDERS
- Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease
- (2010) Ray L. Watts et al. MOVEMENT DISORDERS
- What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?
- (2010) David A. Gallagher et al. MOVEMENT DISORDERS
- Apomorphine effect on pain threshold in Parkinson's disease: A clinical and positron emission tomography study
- (2010) Estelle Dellapina et al. MOVEMENT DISORDERS
- Neuroprotection of Pramipexole in UPS Impairment Induced Animal Model of Parkinson’s Disease
- (2010) Chao Li et al. NEUROCHEMICAL RESEARCH
- An anti-Parkinson drug ropinirole depletes orexin from rat hypothalamic slice culture
- (2010) Shotaro Michinaga et al. NEUROSCIENCE RESEARCH
- Continuous dopaminergic stimulation by pramipexole is effective to treat early morning akinesia in animal models of Parkinson's disease: A pharmacokinetic-pharmacodynamic study using in vivo microdialysis in rats
- (2010) Boris Ferger et al. SYNAPSE
- Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
- (2009) ARCHIVES OF NEUROLOGY
- Safety and Tolerability of Pardoprunox, a New Partial Dopamine Agonist, in a Randomized, Controlled Study of Patients with Advanced Parkinson’s Disease
- (2009) R.A. Hauser et al. EUROPEAN NEUROLOGY
- Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction
- (2009) K.A. Stockwell et al. EXPERIMENTAL NEUROLOGY
- Continuous rotigotine administration reduces dyskinesia resulting from pulsatile treatment with rotigotine or l-DOPA in MPTP-treated common marmosets
- (2009) K.A. Stockwell et al. EXPERIMENTAL NEUROLOGY
- Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson’s disease: a meta analysis
- (2009) R. Talati et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- The dopamine D2 receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with l-dopa
- (2009) Michael John Jackson et al. JOURNAL OF NEURAL TRANSMISSION
- Neuroprotective effect of l-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson’s disease: a direct comparison study
- (2009) Jin Young Shin et al. JOURNAL OF NEUROCHEMISTRY
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
- Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice
- (2009) Masatoshi Inden et al. NEUROCHEMISTRY INTERNATIONAL
- Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease
- (2009) Jee-Young Lee et al. PARKINSONISM & RELATED DISORDERS
- Cabergoline and pramipexole fail to modify already established dyskinesias in an animal model of parkinsonism
- (2008) Celia Larramendy et al. BEHAVIOURAL BRAIN RESEARCH
- Effects of Ropinirole on Nonmotor Symptoms of Parkinson Disease
- (2008) Irena Rektorova et al. CLINICAL NEUROPHARMACOLOGY
- Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets
- (2008) K.A. Stockwell et al. EXPERIMENTAL NEUROLOGY
- Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response
- (2008) Mahmoud M. Iravani et al. EXPERIMENTAL NEUROLOGY
- An expert opinion on safinamide in Parkinson's disease
- (2008) Marco Onofrj et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways
- (2008) Sheng Chen et al. FEBS LETTERS
- Differential Modulation of Akt/Glycogen Synthase Kinase-3β Pathway Regulates Apoptotic and Cytoprotective Signaling Responses
- (2008) Venugopalan D. Nair et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements
- (2008) Werner J. Schmidt et al. JOURNAL OF NEURAL TRANSMISSION
- Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents
- (2008) A. Marighetto et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson’s disease
- (2008) Dieter Scheller et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD
- (2008) R. Katzenschlager et al. NEUROLOGY
- Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease
- (2008) Dieter Scheller et al. NEUROSCIENCE LETTERS
- Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat
- (2008) Anna R. Carta et al. SYNAPSE
- Nonmotor symptoms of Parkinson's disease: Prevalence and awareness of patients and families
- (2007) Sang-Myung Cheon et al. PARKINSONISM & RELATED DISORDERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started